OFI Technologie & Innovation GmbH

  • Progress in good hands
About OFI Technologie & Innovation GmbH

The research and testing institute OFI provides assistance for the targeted, efficient development of your new products. Your concerns will always be given priority. Why? Because, rather than developing our own products, we act as a 100% privately owned, independent and self-funded laboratory. Whether medicines are in the development or authorisation stage, or already on the market, we offer you international services based on GMP, EMA and US guidelines, including:

Quality Control and Development: Drug Release and Raw Material Testing, Method Development and Validation, Stability assessment studies

Pharmaceutical Packaging: Material Release Testing, CCI-testing, Extractables & Leachables

Medical Devices: Biocompatibility testing

Investigations: Expert Center Particles, Impurities, Nitrosamines

  • AT
  • 2016
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Contract Service
Primary activities
Analytical Services
Laboratory Services
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Germany
1-3 November 2022

Products from OFI Technologie & Innovation GmbH (5)

  • Container Closure Integrity (CCI)

    Product Container Closure Integrity (CCI)

    Container closure integrity testing (CCIT) ensures adequate pharmaceutical packaging for your product. As an independent partner, OFI offers the optimal method of analysis for your packaging system.

    Non-destructive testing of glass vials is performed by laser headspace analysis for oxygen ...
  • Packaging Release

    Product Packaging Release

    Pharmaceutical packaging serves an important protective function for your medicines and as such is a crucial part of your product.

    OFI performs all necessary tests for you to ensure its quality, from compendial testing, to CCI testing, and extractables & leachables testing. We offer in-...
  • Biocompatibility

    Product Biocompatibility

    One focus of OFI is the evaluation of medical device biocompatibility. In accordance with the ISO 10993, a risk-based approach is used to obtain meaningful results and address product-specific requirements.

    Our testing expertise includes in vitro testing for cytotoxicity according to ISO...
  • Elemental impurities - AAS and ICP

    Product Elemental impurities - AAS and ICP

    The quantification and trace analysis of a substantial number of elements is required for compendial assays and impurity tests as well as extractables & leachables testing.

    OFI performs compendial testing for e.g. heavy metals in polymers under GMP, screening for elemental impurities a...
  • Investigations of Nitrosamines and other Impurities

    Product Investigations of Nitrosamines and other Impurities

    Our expertise is in assessing your product for impurities.

    Nitrosamines are a harmful class of impurities which can form from secondary amines and nitrite under acidic conditions. We test raw materials for nitrite and support you in providing a safe and nitrosamine-free product through analy...

OFI Technologie & Innovation GmbH Resources (1)